Dr. Wang gave a presentation about tissue engineering and regenerative medicine using organoids at Translational Medicine and Stem Cell Association (TMSCA) at UC Berkeley. The most recent research progress on biomaterials mediated organoids and stem cell reprogramming and organoids and cell-mediated drug delivery has been discussed. Stem cell research at UC Berkeley is organized and coordinated by the Berkeley Stem Cell Center, a cornerstone of the University’s Health Sciences Initiative.
Our drug delivery paper, “Folate Receptor-Targeted and
GSH-Responsive Carboxymethyl Chitosan Nanoparticles Containing
Covalently Entrapped 6-Mercaptopurine for Enhanced Intracellular Drug
Delivery in Leukemia“, is among the Top 25 Most Cited Papers of Marine
Drugs, since 2018. Congratulations!